9 Diagnostics advisory committee members and NICE project team

9 Diagnostics advisory committee members and NICE project team

Diagnostics advisory committee

The diagnostics advisory committee is an independent committee consisting of 22 standing members and additional specialist members. A list of the committee members who participated in this assessment appears below.

Standing committee members

Dr Trevor Cole
Consultant Clinical Geneticist, Birmingham Women's Hospital Foundation Trust

Dr Simon Fleming
Consultant in Clinical Biochemistry and Metabolic Medicine, Royal Cornwall Hospital

Professor Noor Kalsheker
Professor of Clinical Chemistry, Molecular Medical Sciences, University of Nottingham

Dr Mark Kroese
Consultant in Public Health Medicine, PHG Foundation and UK Genetic Testing Network

Professor Adrian Newland (Chair)
Consultant Haematologist, Barts and the London NHS Trust

Dr Richard Nicholas
Consultant Neurologist, Heatherwood and Wexham Park Hospital, Imperial Healthcare Trust

Ms Margaret Ogden
Lay member

Professor Mark Sculpher
Professor of Health Economics, University of York

Professor Ron Akehurst
Professor in Health Economics, School of Health & Related Research (ScHARR) University of Sheffield

Dr Steve Thomas
Senior Lecturer and Consultant Radiologist, University of Sheffield

Dr Sue Crawford
General Practitioner (GP) Principal, The Health Centre, Devon

Mr Christopher Wiltsher
Lay member

Specialist committee members

Dr Tim Hoare
Consultant Radiologist with Special Interest in Abdominal Imaging, Newcastle Hospitals NHS Trust

Mrs Gail Coster
Advanced Practitioner Sonographer, Mid Yorkshire Hospitals NHS Trust

Mrs Jane Smith
Consultant Sonographer Practitioner, St James's University Hospital

Dr Kofi Ernest Oppong
Consultant Gastroenterologist, Newcastle Hospitals NHS Trust

Mr Richard Hall
Patient Support Group Manager, British Liver Trust

NICE project team

Each diagnostics assessment is assigned to a team consisting of 1 technical analyst (who acts as the topic lead), a technical adviser and a project manager.

Gurleen Jhuti
Topic Lead

Hanan Bell
Technical Adviser

Jackson Lynn
Project Manager

Sources of evidence considered by the committee

The diagnostics assessment report for this evaluation was prepared by the Kleijnen Systematic Reviews Ltd Assessment Group.

  • Westwood M, Joore M, Grutters J. et al. Contrast enhanced ultrasound using SonoVue (sulphur hexafluoride microbubbles), compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging, for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis. January 2012.

Registered stakeholders

Registered stakeholders were recruited from the following organisations but do not necessarily represent the views of that organisation. They were invited to attend the scoping workshop and to comment on the diagnostics assessment report and the diagnostics consultation document.

Manufacturers/sponsors

Technology under consideration:

  • Bracco UK Ltd.

Comparator(s):

  • None.

Other:

  • GE Healthcare.

Professional/specialist and patient/carer groups
  • Royal College of Nursing

  • British Medical Ultrasound Society

  • Echocardiography Department, Princess Royal University Hospital, London

  • Gateshead Health NHS Foundation Trust

  • British Liver Trust

  • British Society of Gastrointestinal and Abdominal Radiology

  • Peterborough City Hospital.

ISBN: 978-1-4731-0912-4

  • National Institute for Health and Care Excellence (NICE)